epidermal growth factors การใช้

• It binds to the epidermal growth factor receptor ( EGFR ).
• The drug is a so-called epidermal growth factor receptor antagonist.
• Paracrine signalling mediates the response to epidermal growth factor receptor kinase inhibitors.
• AP26113 is a dual inhibitor of ALK and epidermal growth factor receptor.
• Both Herceptin and IMC-C225 are antibodies that block epidermal growth factor receptors.
• The drug is one of several in development called epidermal growth factor receptor inhibitors.
• Epidermal growth factor and its receptor was discovered by Stanley Cohen of Vanderbilt University.
• Epidermal growth factor receptor ( EGFR ) inhibitors are medications used in cancer treatment.
• It binds to the epidermal growth factor receptor ( EGFR ) with high affinity.
• He discovered this in studies of the epidermal growth factor receptor ( EGFR ).
• The tumors must not have an epidermal growth factor receptor or anaplastic lymphoma kinase.
• Both inhibit epidermal growth factor receptors, which have a role in triggering tumor growth.
• Paracrine activates epidermal growth factor receptor in endothelial cells of the tumor to do this.
• The epidermal growth factor receptor system, as such, has been used as an intermediate example.
• SHC1 has been found to act in signaling information after epidermal growth factor ( EGF ) stimulation.
• PTPN1 has been shown to interact with BCAR1, epidermal growth factor receptor, Grb2 and IRS1.
• This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains.
• This gene encodes a cytoplasmic protein that contains epidermal growth factor ( EGF )-like repeats.
• Drugs of this type include those that target the epidermal growth factor receptors of VEGFR inhibitors ).
• _AstraZeneca's drug known as ZD1839 is designed to block a protein, epidermal growth factor.